MAAsiRNA
PrivateLast Round
Accelerator
Nov 24, 2023
Total Funding Raised
$750,000
Company Overview
MAAsiRNA is a biotechnology company that develops siRNA-based targeted therapies for nervous system pathologies, including Charcot-Marie-Tooth disease type 1A.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MAAsiRNA Comparables
Compare MAAsiRNA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Armatus Bio | 86% | |
| Shark Tooth Bio | 84% | |
| Nervosave Therapeutics | 83% |
MAAsiRNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Nov 24, 2023 |
MAAsiRNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SATT Paris-Saclay | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 24, 2023
$750K raised, led by SATT Paris-Saclay.
MAAsiRNA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MAAsiRNA's valuation, stock price, and market status.
Is MAAsiRNA a public or private company?
MAAsiRNA is a private company.
What is the current stock price of MAAsiRNA?
MAAsiRNA is a private company with no public stock price. Caplight tracks MAAsiRNA's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is MAAsiRNA worth (valuation)?
Valuation information for MAAsiRNA is not publicly available.
Can I buy MAAsiRNA stock?
MAAsiRNA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MAAsiRNA's last funding round?
MAAsiRNA's most recent funding round was Accelerator on November 24, 2023.
Who are the main investors in MAAsiRNA?
Key investors in MAAsiRNA include SATT Paris-Saclay.
Will MAAsiRNA IPO soon?
No public IPO plans have been announced for MAAsiRNA.
How can I track MAAsiRNA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MAAsiRNA's secondary market activity and sign up for updates.